Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets

Recruiting

Phase 1

AdagrasibBioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets

Sponsor:

Mirati Therapeutics Inc.

Code:

NCT06801418

Conditions

Healthy Volunteers

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Accepted

Interventions

Adagrasib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Mirati Therapeutics Inc. on 2025-02-28.